Deborah A. Tweddle

Framlington Place
Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Journal: JCO precision oncology

Published: July 16, 2026

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Journal: JCO precision oncology

Published: July 01, 2026

Detection and Characterisation of Circulating Tumour Cell Clusters in Neuroblastoma.

Detection and Characterisation of Circulating Tumour Cell Clusters in Neuroblastoma.

Journal: Cancers

Published: December 23, 2025

Current treatment strategies for first relapse of high-risk neuroblastoma.

Current treatment strategies for first relapse of high-risk neuroblastoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 16, 2025

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 12, 2025

Temporal clustering of neuroblastic tumours in children and young adults from Scotland.

Temporal clustering of neuroblastic tumours in children and young adults from Scotland.

Journal: Environmental health : a global access science source

Published: October 17, 2025

Detection of GD2 negative circulating tumour cells in neuroblastoma by machine learning.

Detection of GD2 negative circulating tumour cells in neuroblastoma by machine learning.

Journal: Cancer letters

Published: October 07, 2025

Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA.

Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA.

Journal: International journal of molecular sciences

Published: August 12, 2025

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.

Journal: British journal of cancer

Published: June 18, 2025

Germline duplication of MYCN predisposes to childhood embryonal tumours.

Germline duplication of MYCN predisposes to childhood embryonal tumours.

Journal: EBioMedicine

Published: June 05, 2025

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Journal: The Journal of molecular diagnostics : JMD

Published: April 08, 2025

Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998.

Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998.

Journal: Cancers

Published: August 05, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026